4.7 Article

Moderate decline in select synaptic markers in the prefrontal cortex (BA9) of patients with Alzheimer's disease at various cognitive stages

期刊

SCIENTIFIC REPORTS
卷 8, 期 -, 页码 -

出版社

NATURE PORTFOLIO
DOI: 10.1038/s41598-018-19154-y

关键词

-

资金

  1. ANR [ANR-09-MNPS-033]
  2. ANR/CIHR [ANR-10-MALZ-0105, ANR-10-MALZ-0003]
  3. FRC [AO 2011]
  4. CFI [203624]
  5. CRC [CRC - 216124]
  6. FRSQ-S
  7. Douglas Foundation
  8. Graham Boeckh Foundation
  9. INSERM
  10. CNRS
  11. UPMC
  12. Agence Nationale de la Recherche (ANR) [ANR-10-MALZ-0105, ANR-10-MALZ-0003] Funding Source: Agence Nationale de la Recherche (ANR)

向作者/读者索取更多资源

Synaptic loss, plaques and neurofibrillary tangles are viewed as hallmarks of Alzheimer's disease (AD). This study investigated synaptic markers in neocortical Brodmann area 9 (BA9) samples from 171 subjects with and without AD at different levels of cognitive impairment. The expression levels of vesicular glutamate transporters (VGLUT1&2), glutamate uptake site (EAAT2), post-synaptic density protein of 95 kD (PSD95), vesicular GABA/glycine transporter (VIAAT), somatostatin (som), synaptophysin and choline acetyl transferase (ChAT) were evaluated. VGLUT2 and EAAT2 were unaffected by dementia. The VGLUT1, PSD95, VIAAT, som, ChAT and synaptophysin expression levels significantly decreased as dementia progressed. The maximal decrease varied between 12% (synaptophysin) and 42% (som). VGLUT1 was more strongly correlated with dementia than all of the other markers (polyserial correlation = -0.41). Principal component analysis using these markers was unable to differentiate the CDR groups from one another. Therefore, the status of the major synaptic markers in BA9 does not seem to be linked to the cognitive status of AD patients. The findings of this study suggest that the loss of synaptic markers in BA9 is a late event that is only weakly related to AD dementia.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据